A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
about
Adjuvant systemic therapy in older women with breast cancerCapecitabine in Combination with Standard (Neo)Adjuvant Regimens in Early Breast Cancer: Survival Outcome from a Meta-Analysis of Randomized Controlled Trials.Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly.nab-Paclitaxel for the treatment of breast cancer: an update across treatment settingsAdjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.An update on adjuvant systemic therapy for elderly patients with early breast cancer.Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer.
P2860
Q26741523-71B3C872-8D95-410C-B569-52178437E485Q36163866-976E6081-ECC8-4702-BF03-95B51D903BD1Q37570641-9E851628-B4BE-4F62-B994-FD782BCB7C4FQ37715554-43732B47-472E-4B94-A3D7-F1F338066C1DQ38380059-4A06B3A1-E86B-4A2C-B790-1C35B57B20D7Q38772800-2CA01516-914B-4403-9E37-E274537DD568Q38787215-F23D46A1-AD52-4BD6-B9DB-A6F7B847DFF5Q38931502-497837B9-9FD7-40F0-AEC6-35682567414EQ50089357-B64AEAD8-CDCB-43EF-B4AE-0E54C0C30C22
P2860
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@ast
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@en
type
label
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@ast
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@en
prefLabel
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@ast
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@en
P2093
P2860
P50
P356
P1433
P1476
A randomized phase 2 study com ...... breast cancer (ICE II-GBG 52).
@en
P2093
Bettina Conrad
Carsten Denkert
Christian Jackisch
Christoph Thomssen
Eike Simon
Elmar Stickeler
Frederik Marmé
German Breast Group Investigators
Joachim Alfer
Jochem Potenberg
P2860
P304
P356
10.1002/CNCR.29506
P407
P577
2015-06-25T00:00:00Z